PAPER Perluigi M, Di Domenico F, Barone E, Butterfield DA
SEARCH RESULTS
4801 RESULTS
PAPER Kiss E, Kins S, Zöller Y, Schilling S, Gorgas K, Groß D, Schlicksupp A, Rosner R, Kirsch J, Kuhse J
Artesunate restores the levels of inhibitory synapse proteins and reduces amyloid-β and C-terminal fragments (CTFs) of the amyloid precursor protein in an AD-mouse model.
Mol Cell Neurosci. 2021 Jun;113:103624. Epub 2021 Apr 30 PubMed: 33933588PAPER Zheng YB, Shi L, Zhu XM, Bao YP, Bai LJ, Li JQ, Liu JJ, Han Y, Shi J, Lu L
Anticholinergic drugs and the risk of dementia: A systematic review and meta-analysis.
Neurosci Biobehav Rev. 2021 Aug;127:296-306. Epub 2021 Apr 29 PubMed: 33933505PAPER Dubois B, Villain N, Frisoni GB, Rabinovici GD, Sabbagh M, Cappa S, Bejanin A, Bombois S, Epelbaum S, Teichmann M, Habert MO, Nordberg A, Blennow K, Galasko D, Stern Y, Rowe CC, Salloway S, Schneider LS, Cummings JL, Feldman HH
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group.
Lancet Neurol. 2021 Jun;20(6):484-496. Epub 2021 Apr 29 PubMed: 33933186PAPER Jagust WJ
The changing definition of Alzheimer's disease.
Lancet Neurol. 2021 Jun;20(6):414-415. Epub 2021 Apr 29 PubMed: 33933185PAPER West T, Kirmess KM, Meyer MR, Holubasch MS, Knapik SS, Hu Y, Contois JH, Jackson EN, Harpstrite SE, Bateman RJ, Holtzman DM, Verghese PB, Fogelman I, Braunstein JB, Yarasheski KE
A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis.
Mol Neurodegener. 2021 May 1;16(1):30. PubMed: 33933117PAPER Balmik AA, Sonawane SK, Chinnathambi S
The extracellular HDAC6 ZnF UBP domain modulates the actin network and post-translational modifications of Tau.
Cell Commun Signal. 2021 May 1;19(1):49. PubMed: 33933071PAPER Probst S, Riese F, Kägi L, Krüger M, Russi N, Nitsch RM, Konietzko U
Lysine acetyltransferase Tip60 acetylates the APP adaptor Fe65 to increase its transcriptional activity.
Biol Chem. 2021 Mar 26;402(4):481-499. Print 2021 Mar 26 PubMed: 33938178PAPER Ma LZ, Zhang C, Wang H, Ma YH, Shen XN, Wang J, Tan L, Dong Q, Yu JT
Serum Neurofilament Dynamics Predicts Cognitive Progression in de novo Parkinson's Disease.
J Parkinsons Dis. 2021;11(3):1117-1127. PubMed: 33935105PAPER Vemuri P, Graff-Radford J, Lesnick TG, Przybelski SA, Reid RI, Reddy AL, Lowe VJ, Mielke MM, Machulda MM, Petersen RC, Knopman DS, Jack CR Jr
White matter abnormalities are key components of cerebrovascular disease impacting cognitive decline.
Brain Commun. 2021;3(2):fcab076. Epub 2021 Apr 12 PubMed: 33937772PAPER Boa Sorte Silva NC, Petrella AF, Christopher N, Marriott CF, Gill DP, Owen AM, Petrella RJ
The Benefits of High-Intensity Interval Training on Cognition and Blood Pressure in Older Adults With Hypertension and Subjective Cognitive Decline: Results From the Heart & Mind Study.
Front Aging Neurosci. 2021;13:643809. Epub 2021 Apr 15 PubMed: 33935686PAPER Liu Y, Chen L, Huang S, Lv Z, Hu L, Luo J, Shang P, Wang Y, Xie H
Sleep duration and efficiency are associated with plasma amyloid-β7 in non-demented older people.
Neurol Sci. 2021 May 2; PubMed: 33934274PAPER Ren D, Lopez OL, Lingler JH, Conley Y
Association Between the APOEɛ2/ɛ4 Genotype and Alzheimer's Disease and Mild Cognitive Impairment Among African Americans.
J Alzheimers Dis. 2021;81(3):943-948. PubMed: 33935088PAPER Wang YY, Ge YJ, Tan CC, Cao XP, Tan L, Xu W
The Proportion of APOE4 Carriers Among Non-Demented Individuals: A Pooled Analysis of 389,000 Community-Dwellers.
J Alzheimers Dis. 2021;81(3):1331-1339. PubMed: 33935087Linda Martin
Littleton, United States
Current Filters
- Date Range : Feb 2021 to May 2021 x